
Demant A/S
CSE:DEMANT

Gross Margin
Demant A/S
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
Country | Company | Market Cap |
Gross Margin |
||
---|---|---|---|---|---|
DK |
![]() |
Demant A/S
CSE:DEMANT
|
59.2B DKK |
76%
|
|
US |
![]() |
Abbott Laboratories
NYSE:ABT
|
218.9B USD |
56%
|
|
US |
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
174.7B USD |
67%
|
|
US |
![]() |
Boston Scientific Corp
NYSE:BSX
|
159.4B USD |
69%
|
|
US |
![]() |
Stryker Corp
NYSE:SYK
|
153.2B USD |
65%
|
|
IE |
![]() |
Medtronic PLC
NYSE:MDT
|
118B USD |
66%
|
|
DE |
![]() |
Siemens Healthineers AG
XETRA:SHL
|
52.2B EUR |
39%
|
|
US |
![]() |
Becton Dickinson and Co
NYSE:BDX
|
52.3B USD |
45%
|
|
US |
![]() |
Edwards Lifesciences Corp
NYSE:EW
|
45.3B USD |
79%
|
|
US |
![]() |
IDEXX Laboratories Inc
NASDAQ:IDXX
|
43.7B USD |
61%
|
|
US |
![]() |
Resmed Inc
NYSE:RMD
|
40.1B USD |
59%
|
Demant A/S
Glance View
Demant A/S, an eminent player in the world of hearing healthcare, finds its roots in Denmark, where it was founded in 1904. The journey, sparked by the compassion of founder Hans Demant who sought ways to improve his wife's hearing experience, has evolved into a global operation focused on improving quality of life through innovative hearing solutions. Demant transcends beyond traditional hearing aids, carving a niche in providing a broad range of hearing healthcare services. These include audiometric equipment, hearing implants, diagnostic instruments, and personal communication applications, all aligned with the mission to help people overcome communication barriers. Key to Demant's strategy is its strong emphasis on research and development, ensuring that it remains at the forefront of technological advancements in audiology. The company monetizes its operations through a combination of cutting-edge product sales and a suite of ancillary services that cater to different segments of the hearing healthcare market. Leveraging a robust distribution network, Demant ensures a wide market reach, with offerings meticulously tailored to meet regional consumer needs. Collaborations with retailers, hospitals, and clinics across the globe amplify its market penetration, driving both revenue and brand loyalty. Additionally, Demant taps into the growing demand for auditory digital health solutions, offering cloud-based services that integrate seamlessly into consumer lifestyles. This multifaceted approach not only diversifies revenue streams but also fortifies Demant's standing as a holistic hearing solutions provider, underpinned by a commitment to enhancing living through auditory wellness.

See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Demant A/S's most recent financial statements, the company has Gross Margin of 76.2%.